
Acceda a las conferencias en idioma inglés y en formato PDF
1. Vigilancia:
• Natural History of Disease and Biological Aspects of Influenza A
(H1N1)
• Influenza A (H1/N1) Pandemic
Dr. Timothy M. Uyeki, Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, CDC
Vigilancia en diferentes ámbitos
• Human Surveillance
Prof. Nigel Lightfoot, C.B.E. Chief Advisor, Emergency Preparedness and Head of Influenza Programme Health Protection Agency
• Animal Surveillance
Dr. Brian Evans. Executive Vice-President, Canadian Food Inspection Agency
2. Medidas en fronteras y aeropuertos
• Screening Travelers at Borders During a Pandemic: Some Thoughts About Tools
Dr. Peter Houck. Division of Global Migration & Quarantine (DGMQ), CDC
3. Vigilancia en sitios turísticos
• Disease Surveillance in Tourists
Dr. Gary Brunette. Division of Global Migration & Quarantine (DGMQ), CDC
4. Espectro clínico de la enfermedad
• Spectrum of desease influenza A H1N1
Dr. Rogelio Pérez Padilla. General Director of the National Institute of the National Institute of Respiratory Diseases, Mexico
• Clinical Issues - Pandemic Influenza A (H1N1) Virus Infection
Dr. Timothy M. Uyeki. Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, CDC
• Influenza A H1N1 New York City and MSKCC EXPERIENCE
Dr. Carlos M. Jaramillo Hoyos. Infectious Diseases Department, Memorial Sloan-Kettering Cancer Center, US
• Clinical spectrum of disease, Mortality related to influenza A (H1 N1) in Mexico
Dr. Germán Fajardo Dolci. CONAMED, Mexico
5. Capacidad y respuesta hospitalaria
• Capacidad y respuesta hospitalaria
Dr. Alejandro Macías. Infectologist. National Institute of Health Sciences and Nutrition, Salvador Zubirán, Mexico
6. Tratamiento y profilaxis
• Antiviral Treatment and Chemoprophylaxis of Pandemic Influenza A (H1N1) Virus
Dr. Timothy M. Uyeki, Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, CDC
• U.S. Strategic National Stockpile: Strategies for Influenza Mitigation
Mr. Steven Adams. Deputy Director, Division of National Strategic Stockpile (DSNS), CDC
7. Medidas de Salud Pública
• Pandemic Novel H1N1 Influenza Surveillance, United States
Dr. Nancy Cox, Director of Influenza Division, CDC
8. Vaccines
• Influenza Vaccines
Dr. Nancy Cox, Director of Influenza Division, CDC
• 2009 Pandemic Public Health Measures: Vaccine, Comprehensive Family Immunization Project Family and Community Health
Dr. Jon Kim Andrus, Lead Technical Advisor for the Immunization Unit of the Pan American Health Organization, PAHO
9. Planes operativos: del plan a la acción
• Vaccines. Operationalization of Pandemic Plans – from Plan to Action
Dr. Walter Orenstein. Deputy Director Vaccine-Preventable Diseases.
• Externalidades
Dr. Rogelio Granguillhome. Chief of International Cooperation and Economic Relations Unit. Ministry for Foreign Affairs, Mexico
Publicado el 20 de julio de 2009
Reunión de expertos en México
Conferencias Influenza A (H1/N1)
Acceso a las ponencias de destacados especialistas presentadas en la reunión realizada en el mes de Julio en México.
Acceda a las conferencias en idioma inglés y en formato PDF
1. Vigilancia:
• Natural History of Disease and Biological Aspects of Influenza A
(H1N1)
• Influenza A (H1/N1) Pandemic
Dr. Timothy M. Uyeki, Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, CDC
Vigilancia en diferentes ámbitos
• Human Surveillance
Prof. Nigel Lightfoot, C.B.E. Chief Advisor, Emergency Preparedness and Head of Influenza Programme Health Protection Agency
• Animal Surveillance
Dr. Brian Evans. Executive Vice-President, Canadian Food Inspection Agency
2. Medidas en fronteras y aeropuertos
• Screening Travelers at Borders During a Pandemic: Some Thoughts About Tools
Dr. Peter Houck. Division of Global Migration & Quarantine (DGMQ), CDC
3. Vigilancia en sitios turísticos
• Disease Surveillance in Tourists
Dr. Gary Brunette. Division of Global Migration & Quarantine (DGMQ), CDC
4. Espectro clínico de la enfermedad
• Spectrum of desease influenza A H1N1
Dr. Rogelio Pérez Padilla. General Director of the National Institute of the National Institute of Respiratory Diseases, Mexico
• Clinical Issues - Pandemic Influenza A (H1N1) Virus Infection
Dr. Timothy M. Uyeki. Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, CDC
• Influenza A H1N1 New York City and MSKCC EXPERIENCE
Dr. Carlos M. Jaramillo Hoyos. Infectious Diseases Department, Memorial Sloan-Kettering Cancer Center, US
• Clinical spectrum of disease, Mortality related to influenza A (H1 N1) in Mexico
Dr. Germán Fajardo Dolci. CONAMED, Mexico
5. Capacidad y respuesta hospitalaria
• Capacidad y respuesta hospitalaria
Dr. Alejandro Macías. Infectologist. National Institute of Health Sciences and Nutrition, Salvador Zubirán, Mexico
6. Tratamiento y profilaxis
• Antiviral Treatment and Chemoprophylaxis of Pandemic Influenza A (H1N1) Virus
Dr. Timothy M. Uyeki, Deputy Chief, Epidemiology and Prevention Branch, Influenza Division, CDC
• U.S. Strategic National Stockpile: Strategies for Influenza Mitigation
Mr. Steven Adams. Deputy Director, Division of National Strategic Stockpile (DSNS), CDC
7. Medidas de Salud Pública
• Pandemic Novel H1N1 Influenza Surveillance, United States
Dr. Nancy Cox, Director of Influenza Division, CDC
8. Vaccines
• Influenza Vaccines
Dr. Nancy Cox, Director of Influenza Division, CDC
• 2009 Pandemic Public Health Measures: Vaccine, Comprehensive Family Immunization Project Family and Community Health
Dr. Jon Kim Andrus, Lead Technical Advisor for the Immunization Unit of the Pan American Health Organization, PAHO
9. Planes operativos: del plan a la acción
• Vaccines. Operationalization of Pandemic Plans – from Plan to Action
Dr. Walter Orenstein. Deputy Director Vaccine-Preventable Diseases.
• Externalidades
Dr. Rogelio Granguillhome. Chief of International Cooperation and Economic Relations Unit. Ministry for Foreign Affairs, Mexico